מרונם 500 מג

Country: Israel

Language: Hebrew

Source: Ministry of Health

Active ingredient:

MEROPENEM AS TRIHYDRATE

Available from:

PFIZER PFE PHARMACEUTICALS ISRAEL LTD

ATC code:

J01DH02

Pharmaceutical form:

אבקה להכנת תמיסה לזריקה

Composition:

MEROPENEM AS TRIHYDRATE 500 MG/VIAL

Administration route:

תוך-ורידי

Prescription type:

מרשם נדרש

Manufactured by:

ASTRA ZENECA UK LIMITED

Therapeutic group:

MEROPENEM

Therapeutic area:

MEROPENEM

Therapeutic indications:

Meronem is indicated for treatment in adults and children of the following severe infections caused by single or multiple susceptible bacteria sensitive to meropenem: - Pneumonias and nosocomial pneumonias. - Pulmonary infections in patients with cystic fibrosis. - Urinary tract infections. - Intra-abdominal infections. - Gynecological infections such as endometritis and pelvic inflammatory disease. - Skin and skin structure infections. - Meningitis. - Septicemia. Meronem has proved efficacious alone or in combination with other antimicrobial agents in the treatment of polymicrobial infections. There is no experience in pediatric patients with neutropenia or primary or secondary immunodeficiency.

Authorization date:

2012-01-31